Abstract

BackgroundApremilast (APR), an oral phosphodiesterase 4 inhibitor, works intracellularly to regulate inflammatory mediators. The PALACE 1, 2, and 3 trials compared the efficacy and safety of APR with placebo (PBO)...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
THU0416 Disease Activity and Safety During Long-Term (104-Week) Treatment with Apremilast, An Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomized, Controlled Trial and Open-Label Extension (Palace 3)
C Edwards ... F Blanco
Annals of the Rheumatic Diseases | VOL. 74
C Edwards, et. al.C Edwards ... F Blanco
01 Jun 2015
SAT0078 MAJOR CHANGES IN THERAPY PRODUCE SIGNIFICANT CLINICAL IMPROVEMENT ACROSS A BROAD RANGE OF CLINICAL DISEASE ACTIVITY IN US VETERANS WITH RHEUMATOID ARTHRITIS
Grant Cannon ... David Collier
-
Grant Cannon, et. al.Grant Cannon ... David Collier
01 Jun 2019
SAT0392 Work Productivity Improvement Associated with Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results of A Phase 3, Randomized, Controlled Trial
F Zhang ... S Li
Annals of the Rheumatic Diseases | VOL. 73
F Zhang, et. al.F Zhang ... S Li
01 Jun 2014
SAT0568 Long-Term Work Productivity Improvement Associated with Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Analysis of 3 Phase 3 Studies
F Zhang ... Z Clancy
Annals of the Rheumatic Diseases | VOL. 74
F Zhang, et. al.F Zhang ... Z Clancy
01 Jun 2015
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
From fibrositis to fibromyalgia to nociplastic pain: how rheumatology helped get us here and where do we go from here?
Daniel J Clauw
Annals of the Rheumatic Diseases | VOL. -
Daniel J ClauwDaniel J Clauw
06 Aug 2024
Development of international consensus on a standardised image acquisition protocol for diagnostic evaluation of the sacroiliac joints by MRI: an ASAS–SPARTAN collaboration
Robert G W Lambert ... Walter P Maksymowych
Annals of the Rheumatic Diseases | VOL. -
Robert G W Lambert, et. al.Robert G W Lambert ... Walter P Maksymowych
06 Aug 2024
Journey through discovery of 75 years glucocorticoids: evolution of our knowledge of glucocorticoid receptor mechanisms in rheumatic diseases
Ann-Kathrin Eiers ... Jan P Tuckermann
Annals of the Rheumatic Diseases | VOL. -
Ann-Kathrin Eiers, et. al.Ann-Kathrin Eiers ... Jan P Tuckermann
06 Aug 2024
Helicobacter pylori upregulates PAD4 expression via stabilising HIF-1α to exacerbate rheumatoid arthritis
Hui Wu ... Chao Wu
Annals of the Rheumatic Diseases | VOL. -
Hui Wu, et. al.Hui Wu ... Chao Wu
06 Aug 2024
View more papers